New drug development in head and neck oncology
作者： Mario Eisenberger , Daniel Hoth , Juan Posada
DOI: 10.1007/978-1-4613-3816-1_15
关键词:
摘要: The role of chemotherapy in the treatment squamous cell carcinomas head and neck remains limited to palliation. Multiple single agents combinations have been tested patients failing initial (surgery and/or radiation) resulting an unclear impact on survival. New approaches under extensive evaluation include: (1) development new drugs, (2) testing evolving concepts drug interaction modulation, (3) different routes administration particularly intraarterial route with utilization techniques devices such as prolonged infusion pumps.
springer.com
sci-hub.st 参考文章(95)
Brindley Co, Hall Tc, Owens Ah, Selawry O, Holland Jf, Dederick Mm, Colsky J, Gold Gl, Shnider Bj, Jones R, A clinical study of 5-fluorouracil. Cancer Research. ,vol. 19, pp. 935- 939 ,(1959)
Weichselbaum R, Fabian R, Posner M, Miller D, Ervin Tj, Meshad M, Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer treatment reports. ,vol. 65, pp. 787- ,(1981)
Gerold Fp, Shah J, Strong Ew, Cvitkovic E, Wittes Re, CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck. Cancer treatment reports. ,vol. 61, pp. 359- ,(1977)
Archie W. Prestayko, Bristol Laboratories, Stephen K. Carter, Stanley T. Crooke, Cisplatin : current status and new developments Academic Press. ,(1980)
Marsh Jc, DeConti Rc, Skeel Rt, Bertino, Levitt M, Thomas Ed, Mosher Mb, Farber Lr, Papac Rj, Mitchell Ms, Improved therapeutic index of methotrexate with "leucovorin rescue". Cancer Research. ,vol. 33, pp. 1729- 1734 ,(1973)
Enrico Mihich, CURRENT STUDIES WITH METHYLGLYOXAL-BIS(GUANYLHYDRAZONE). Cancer Research. ,vol. 23, pp. 1375- 1389 ,(1963)
Daniel D. Von Hoff, John Kuhn, Gary Clark, J. William Myers, John F. Sandbach, Robert Pocelinko, Charles A. Coltman, Phase I Clinical Investigation of 9,10-Anthracenedicarboxaldehyde Bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942) Cancer Research. ,vol. 41, pp. 3118- 3121 ,(1981)
Edward T. Creagan, Thomas R. Fleming, John H. Edmonson, James N. Ingle, John E. Woods, Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer Cancer. ,vol. 47, pp. 240- 244 ,(1981) , 10.1002/1097-0142(19810115)47:2<240::AID-CNCR2820470206>3.0.CO;2-7
Bill L. Tranum, Arthur Haut, Saul Rivkin, Edward Weber, Joseph M. Quagliana, Michael Shaw, William G. Tucker, Frank E. Smith, Michael Samson, Jeffrey Gottlieb, A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A Southwest oncology group study Cancer. ,vol. 35, pp. 1148- 1153 ,(1975) , 10.1002/1097-0142(197504)35:4<1148::AID-CNCR2820350420>3.0.CO;2-5
Ronald C. Deconti, David Schoenfeld, A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer Cancer. ,vol. 48, pp. 1061- 1072 ,(1981) , 10.1002/1097-0142(19810901)48:5<1061::AID-CNCR2820480502>3.0.CO;2-X